Copy to clipboard 
Data from a postmarket clinical study demonstrates significant benefits of Neo Medical’s Force Control Technology in spinal fusion.
Specifically, the study highlights clear advantages of Neo’s platform in reducing early screw loosening and improving patient outcomes by managing unintended mechanical stress during surgery.
The clinical study involved 75 patients undergoing thoracolumbar fusion surgery to treat conditions including trauma, spinal stenosis and degenerative disc disease.
Data showed a significant reduction in screw loosening, with the Neo Pedicle Screw System (PSS) demonstrating a screw loosening rate of just 2.7% after one year – 3.4 times lower than the 9.2% rate seen in the control group. This result was enabled by Neo’s Force Control Technology, delivering powerful correction while limiting the unintended stress applied to both the implants and surrounding anatomical structures.
The study also demonstrated substantial improvements in patients’ postoperative daily function. At one year post-surgery, patients treated using Neo’s technology reported disability scores 38% lower than those in the control group, indicating better daily function.
At two-year follow-up, the ODI score dropped still further to 19, with significant reductions in back pain, from a baseline visual analog scale score of 80.3 to 21.6 at one year.
The implant-related revision rate in the Neo group was 4.1%, representing a 58% reduction compared to published data (9.8%).
Neo’s co-founder and CEO, Vincent Lefauconnier, said: “The results of this study highlight the clinical value of our Force Control Technology in reducing some of the most common and damaging complications that too often limit the benefits patients see after surgery. Our goal is to move spine surgery beyond the limits of legacy systems, reimagining treatment processes to make them safer, more efficient, and more effective for every patient.”
Source: Neo Medical
Data from a postmarket clinical study demonstrates significant benefits of Neo Medical's Force Control Technology in spinal fusion.
Specifically, the study highlights clear advantages of Neo's platform in reducing early screw loosening and improving patient outcomes by managing unintended mechanical stress during surgery.
The clinical study...
Data from a postmarket clinical study demonstrates significant benefits of Neo Medical’s Force Control Technology in spinal fusion.
Specifically, the study highlights clear advantages of Neo’s platform in reducing early screw loosening and improving patient outcomes by managing unintended mechanical stress during surgery.
The clinical study involved 75 patients undergoing thoracolumbar fusion surgery to treat conditions including trauma, spinal stenosis and degenerative disc disease.
Data showed a significant reduction in screw loosening, with the Neo Pedicle Screw System (PSS) demonstrating a screw loosening rate of just 2.7% after one year – 3.4 times lower than the 9.2% rate seen in the control group. This result was enabled by Neo’s Force Control Technology, delivering powerful correction while limiting the unintended stress applied to both the implants and surrounding anatomical structures.
The study also demonstrated substantial improvements in patients’ postoperative daily function. At one year post-surgery, patients treated using Neo’s technology reported disability scores 38% lower than those in the control group, indicating better daily function.
At two-year follow-up, the ODI score dropped still further to 19, with significant reductions in back pain, from a baseline visual analog scale score of 80.3 to 21.6 at one year.
The implant-related revision rate in the Neo group was 4.1%, representing a 58% reduction compared to published data (9.8%).
Neo’s co-founder and CEO, Vincent Lefauconnier, said: “The results of this study highlight the clinical value of our Force Control Technology in reducing some of the most common and damaging complications that too often limit the benefits patients see after surgery. Our goal is to move spine surgery beyond the limits of legacy systems, reimagining treatment processes to make them safer, more efficient, and more effective for every patient.”
Source: Neo Medical
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
